BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 8624147)

  • 1. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience.
    Taylor JS; Praditsuwan P; Handel D; Kuffner G
    Arch Dermatol; 1996 May; 132(5):515-8. PubMed ID: 8624147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance.
    Färm G
    Acta Derm Venereol Suppl (Stockh); 1998; 201():1-42. PubMed ID: 9833065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic contact dermatitis to doxepin.
    Brancaccio RR; Weinstein S
    J Drugs Dermatol; 2003 Aug; 2(4):409-10. PubMed ID: 12884464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of previously patch-tested patients referred to a contact dermatitis clinic.
    Soni BP; Sherertz EF
    Am J Contact Dermat; 1997 Mar; 8(1):10-4. PubMed ID: 9066841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group.
    Hillen U; Jappe U; Frosch PJ; Becker D; Brasch J; Lilie M; Fuchs T; Kreft B; Pirker C; Geier J;
    Br J Dermatol; 2006 Apr; 154(4):665-70. PubMed ID: 16536809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Path test reactions to the Chinese Standard Screening Allergens in 1,135 patients investigated for allergic contact dermatitis.
    Liu YQ; Zhao B; Zhuang LH; Fan WX
    Am J Contact Dermat; 1997 Sep; 8(3):141-3. PubMed ID: 9249281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
    Drake LA; Millikan LE
    Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG).
    Löffler H; Becker D; Brasch J; Geier J;
    Br J Dermatol; 2005 Apr; 152(4):709-19. PubMed ID: 15840103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema].
    Vestergaard L; Andersen KE
    Ugeskr Laeger; 1997 Sep; 159(38):5662-6. PubMed ID: 9340873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergic skin disease: investigation of both immediate- and delayed-type hypersensitivity is essential.
    Usmani N; Wilkinson SM
    Clin Exp Allergy; 2007 Oct; 37(10):1541-6. PubMed ID: 17883733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.
    Zug KA; McGinley-Smith D; Warshaw EM; Taylor JS; Rietschel RL; Maibach HI; Belsito DV; Fowler JF; Storrs FJ; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D
    Arch Dermatol; 2008 Oct; 144(10):1329-36. PubMed ID: 18936397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007.
    Wetter DA; Yiannias JA; Prakash AV; Davis MD; Farmer SA; el-Azhary RA
    J Am Acad Dermatol; 2010 Nov; 63(5):789-98. PubMed ID: 20643495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin and laboratory tests: comparison of the epicutaneous patch test with the TTL and LIF tests in the diagnosis of medicamentous allergic contact dermatitis].
    Jovanović M; Poljacki M; Milakov J; Duran V
    Med Pregl; 1992; 45(9-10):365-8. PubMed ID: 1344475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of allergic contact dermatitis in patients with psoriasis vulgaris.
    Clark AR; Sherertz EF
    Am J Contact Dermat; 1998 Jun; 9(2):96-9. PubMed ID: 9601910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience.
    Bonnel RA; La Grenade L; Karwoski CB; Beitz JG
    J Am Acad Dermatol; 2003 Feb; 48(2):294-6. PubMed ID: 12582408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periorbital contact sensitization.
    Landeck L; Schalock PC; Baden LA; Gonzalez E
    Am J Ophthalmol; 2010 Sep; 150(3):366-370.e2. PubMed ID: 20541737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing reactions to a standard series in 608 patients tested from 1990 to 1997 at Massachusetts General Hospital.
    Albert MR; González S; González E
    Am J Contact Dermat; 1998 Dec; 9(4):207-11. PubMed ID: 9810020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and patch test study of patients with positive patch test reactions to fragrance mix in China.
    Lu X; Li LF; Wang W; Wang J
    Contact Dermatitis; 2005 Apr; 52(4):188-91. PubMed ID: 15859990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients.
    Devleeschouwer V; Roelandts R; Garmyn M; Goossens A
    Contact Dermatitis; 2008 Mar; 58(3):159-66. PubMed ID: 18279154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of allergic contact dermatitis due to a topical agent containing chlorpheniramine maleate, with a false-negative patch test.
    Ueno T; Kawana S
    J Dermatol; 2008 Jan; 35(1):46-8. PubMed ID: 18181779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 50.